Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:57 AM
Ignite Modification Date:
2025-12-25 @ 3:57 AM
NCT ID:
NCT07166302
Eligibility Criteria:
Inclusion Criteria:
* Subjects must understand the nature of the study and must provide signed and dated written informed consent prior to conducting any study-related procedures
* Willing and able to comply with all protocol procedures
* subjects confirmed the daily (and recent) intake od direct anticoagulants in strandard dosing.
* no other antitrombotic drug therapy (e.g. acetylsalicyl acid, clopidogrel, ticagralol, low molecular weight heparin or second direct anticoagulant) is taken.
Exclusion Criteria:
* Any clinically significant medical or psychiatric condition or medical history that, in the opinion of the investigator, would interfere with the subject's ability to participate in the study or increase the risk of participation for that subject
* other antitrombotic drug therapy (e.g. acetylsalicyl acid, clopidogrel, ticagralol, low molecular weight heparin or second direct anticoagulant) is recently taken.
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT07166302
Study Brief:
Protocol Section:
NCT07166302